( | ) | ( | ) |
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED |
No. JPCS-22/010
Date: 28 June 2022 | |
Re: | Establishment of a new subsidiary |
To | Director and manager, The Stock Exchange of Thailand |
JSP Pharmaceutical Manufacturing (Thailand) PCL. ("the Company") would like to inform the resolution of the Board of Directors meeting no. 4/2022 on 28 June 2022, which significant resolution was approval of a new subsidiary establishment with details as follow:
The date on which the Board of Directors | 28 | June 2022 |
passed its resolution | ||
The expected date of the establishment | Within August 2022 | |
of subsidiary company | ||
Company name | Caresutic Company Limited | |
Objectives | To generate revenue and profit apart from core business | |
Business description | (1) | Innovation Center to perform research and development |
in dietary supplements and cosmetics | ||
(2) | Small-scale production facility of dietary supplements | |
and cosmetics | ||
Registered capital, number of shares and | Baht 5.00 million, divided to be 50,000 shares with par value | |
par value | of Baht 100 per share | |
Shareholding proportion | The Company will hold 99.99% ownership interest of the | |
authorised capital | ||
Name of directors | (1) | Mrs. Jintana Santipisud |
(2) | Mr. Sittichai Daengprasert | |
(3) | Ms. Jirada Daengprasert | |
Source of fund for establishment of | The Company's working capital | |
subsidiary company | ||
To compute transaction size, the Company used financial information presented in the Company's interim financial information as of 31 March 2022. The highest transaction size was 0.54% based on net tangible assets. In connection with acquisition of assets in the last six months, the highest transaction size was 11.15% based on total value of consideration. In conclusion, this transaction is not required to perform under the
( | ) | ( | ) |
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED |
Notification of the Capital Market Supervisory Board No. Tor Chor 20/2551 and is not a connected transaction. However, this transaction is considered as acquisition of investment in other company; which results other company becomes a subsidiary of a listed company, in accordance with the Regulations of the Stock Exchange of Thailand Re: Rules, Conditions and Procedures Governing the Disclosure of Information and Other Acts of a Listed Company.
Please be informed accordingly.
Sincerely yours,
JSP Pharmaceutical Manufacturing (Thailand) PCL.
Mr. Kriangkrai Rungruangthaweekul
Vice President of Finance
Investor Relations
Tel. 064 479 1691
Emailir@jsppharma.com